Skip to main content
Arquivos Brasileiros de Cirurgia Digestiva : ABCD logoLink to Arquivos Brasileiros de Cirurgia Digestiva : ABCD
. 2014 Jan-Mar;27(1):18–21. doi: 10.1590/S0102-67202014000100005

THE PRESENCE OF METASTASES IN REGIONAL LYMPH NODES IS ASSOCIATED WITH TUMOR SIZE AND DEPTH OF INVASION IN SPORADIC GASTRIC ADENOCARCINOMA

A presença de metástases em linfonodos regionais está associada ao tamanho tumoral e profundidade de invasão no adenocarcinoma gástrico esporádico

Eduardo CAMBRUZZI 1,, Andreza Mariane de AZEREDO 1, Ardala KRONHART 1, Katia Martins FOLTZ 1, Cláudio Galeano ZETTLER 1, Karla Lais PÊGAS 1
PMCID: PMC4675472  PMID: 24676292

Abstract

Background

Gastric adenocarcinoma is more often found in men over 50 years in the form of an antral lesion. The tumor has heterogeneous histopathologic features and a poor prognosis (median survival of 15% in five years).

Aim

To estimate the relationship between the presence of nodal metastasis and other prognostic factors in sporadic gastric adenocarcinoma.

Method

Were evaluated 164 consecutive cases of gastric adenocarcinoma previously undergone gastrectomy (partial or total), without clinical evidence of distant metastasis, and determined the following variables: topography of the lesion, tumor size, Borrmann macroscopic configuration, histological grade, early or advanced lesions, Lauren histological subtype, presence of signet ring cell, degree of invasion, perigastric lymph node status, angiolymphatic/perineural invasion, and staging.

Results

Were found 21 early lesions (12.8%) and 143 advanced lesions (87.2%), with a predominance of lesions classified as T3 (n=99/60, 4%) and N1 (n=62/37, 8%). The nodal status was associated with depth of invasion (p<0.001) and tumor size (p<0.001). The staging was related to age (p=0.048), histological grade (p=0.003), and presence of signet ring cells (p = 0.007), angiolymphatic invasion (p = 0.001), and perineural invasion (p=0.003).

Conclusion

In gastric cancer, lymph node involvement, tumor size and depth of invasion are histopathological data associated with the pattern of growth/tumor spread, suggesting that a wide dissection of perigastric lymph nodes is a fundamental step in the surgical treatment of these patients.

Keywords: Adenocarcinoma, Pathology, Stomach diseases, Prognosis

INTRODUCTION

Gastric cancers are a heterogeneous group of neoplasms, which basically correspond to adenocarcinoma. Gastric cancer mainly affects individuals over 50 years of age, and incidence rates of the disease in males are approximately twice as high as for females. In general, individuals who develop gastric cancer concentrate in the lower economic strata. Risk factors include infection by Helicobacter pylori, loss of E-cadherin expression, p53 gene mutation, overexpression of cyclin D1 and EGFR, and consumption of food containing nitrous compounds. Adenocarcinoma may compromise different regions of the stomach, as well as present different macroscopic forms and histological patterns1,2,5,6,17. Lauren initially described that stomach cancer occurred in two main types, which differed in structure and behavior: intestinal type and diffuse type. The intestinal-type stomach cancer consists of glands similar to those of the intestine and it affects mostly the antrum. It corresponds to the type that most often develops vascular invasion and liver metastases. The diffuse-type stomach cancer is formed by poorly cohesive malignant cells within desmoplastic stroma. It more often affects the stomach body and it is prone to peritoneal spread7. To distinguish between both types seems to be relevant for tumor prognosis1,2,5,6,12,17.

The prognosis is poor, with a mean of only 10-15% of survival at five years, even in patients who previously had curative gastrectomy. Independent prognostic factors seem not to be associated with tumor size and macroscopic configuration; adverse factors include patients over 70 years, proximal location, and lymphovascular invasion. Survival rate is higher for the intestinal type since these tumors occur in younger patients and are less advanced lesions. The strongest prognostic determinant is the pathological stage, which can be determined by the TNM system1,2,3,5,17,18,20.

In the present study, the authors evaluated 164 separate cases of gastric adenocarcinoma in order to determine the association between lymph node metastasis and different prognostic factors.

METHOD

Analytical, cross-sectional and retrospective study in which the authors analyzed 164 separate cases of gastric adenocarcinoma without clinical evidence of distant metastasis, comprising a study period of 120 months (January 2001 to December 2011). The study was approved by the ethics committee of the Grupo Hospitalar Conceição. The cases in the sample corresponded to surgical specimens from partial or total gastrectomy previously evaluated at the laboratory of pathology of the Hospital Conceição de Porto Alegre, in Porto Alegre, RS. All samples were initially fixed in 10% formalin and embedded in paraffin. For diagnostic confirmation of adenocarcinoma following histopathological criteria established by the World Health Organization, 3-μm histological sections were performed for each sample which and then stained by H&E. All cases were evaluated by two pathologists, either individually or jointly. All samples corresponding to stomach biopsy only, other histological types of primary and secondary stomach cancers, as well as the product of gastric resections due to non-neoplastic diseases were excluded. In each case, the following anatomopathological data were determined: lesion topography (cardia, fundus, body and antrum), tumor size in centimeters in the longest axis of the lesion, macroscopic configuration of advanced lesions according Borrmann's classification1,3, differentiation degree (poorly differentiated, moderately differentiated, and well-differentiated), early or advanced lesion, histological subtype according to Lauren's classification (intestinal, diffuse, or mixed), degree of invasion (mucosa, submucosa, muscular, serosa) and spread to adjacent organs, presence signet-ring cells, presence of perineural and lymphovascular invasion, presence of metastases in perigastric lymph nodes, staging according to the TNM classification.

Statistical analysis was performed using tables and descriptive variables (mean and standard deviation). In order to verify the association between the presence of metastasis and the other variables, chi-square and Fisher's exact tests were used. To compare age and tumor size in cases with and without metastasis, Student's t-test for independent samples was used. Results were considered significant at a level of maximum significance of 5%. SPSS statistical software version 10.0 was used was used for processing and analysis.

RESULTS

The mean age among the 164 cases in the sample was of 66.69 years (± 8.568), with a prevalence of malignancy in males (n=111/67, 68%). Mean tumor size was 6.45 cm (± 3.228), with a mean of 13.6 lymph nodes isolated in each specimen. Twenty-one early lesions (12.8%) and 143 advanced lesions (87.2%) were found, with a prevalence of lesions ranked as T3 (n=99/60, 4%) and N1 (n=62/37, 8%). The nodal status was associated with the depth of invasion (p<0.001) and tumor size (p<0.001). The mean tumor size among cases showing metastases in lymph nodes was 7.2 cm, while among cases lacking metastases it was 4.6 cm. The staging was related to age (p=0.048), histological grade (p=0.003), and presence of signet-ring cells (p=0.007), lymphovascular invasion (p=0.001), and perineural invasion (p=0.003). Table 1 shows these findings.

TABLE 1.

Association between the variables analyzed.

  n - % Nodal status (p) Pathological staging (p)
Differentiation level Well 18 – 10.98% 0.269 0.003
Moderately 68 – 41.46%
Poorly 78 – 47.56%
Lauren's histological classification Diffuse 54 – 32.90% 0.793 ---
Intestinal 99 - 60.40%
Mixed 11 – 6.70%
Tumor size ≤ 3.0 cm 23 – 14.02% 0.001 ---
3.1 – 4.9 cm 49 – 29.88%
≥ 5.0 cm 92 – 56.10%
Borrmann's macroscopic conformation – advanced lesions I 20 – 13.98% --- ---
II 35 - 24.47%
III 77 – 53.86%
IV 11 – 7.69%
Topography Cardia 10 – 6,09% --- ---
Fundus 4 – 2,45%
Body 58 – 35.37%
Antrum 92 – 56.09%
Presence of signet-ring cells 52 – 31.7% 0.592 0.007
Presence of neoplastic lymphovascular invasion 113 – 68.9% --- 0.001
Presence of neoplastic perineural invasion 53 – 32.32% --- 0.003
Surgical borders free from neoplasia 137 – 83.54% --- ---
TNM classification T1 21 – 12.80% 0.001 ---
T2 20 – 12.19%
T3 100 – 60.98%
T4 23 – 14.02%
N0 51 – 31.10% --- ---
N1 62 – 37.80%
N2 32 – 19.51%
N3 19 – 11.58%
M0 164 – 100% --- ---
M1 0 – 0%

DISCUSSION

INCA cites an estimated rate of 20,090 new cases of stomach cancer in 2012, of which 12,670 cases in males and 7,420 in females, representing the fifth highest incidence of malignant tumors in Brazil7. Adenocarcinoma accounts for about 95% of stomach malignant neoplasms, and global estimates suggest that this tumoral process is the fourth most common form of cancer and the second most common cause of death by cancer in the world. The incidence of this neoplasia varies considerably, being particularly high in many countries, most often affecting the lower socioeconomic groups and showing a male/female ratio of approximately 2:1. Infection by Helicobacter pylori, especially since childhood, family history of gastric cancer, low socioeconomic status, endogenous production of nitrosamines, high intake of nitroso and irritant compounds, and low consumption of fruits and vegetables are the primary risk factors associated with the development of gastric cancer. In addition to these factors, mutations in the p53 protein, changes in the E-cadherin expression, and potential progression of atrophic gastritis cases also seem to favor the malignant transformation of the gastric mucosa. The survival rate in five years for this cancer is approximately 22% with an estimated length of survival of about 15 months. Factors that influence survival are tumor size, depth of invasion of the serosa, presence of regional and distant lymph node metastasis, and stage of the disease2,3,5,8,9,13,17,18,22.

Moghimi-Dehkordi et al evaluated 746 patients with gastric cancer and found 530 cases in males (mean age of 60.5 years) and 216 cases in females (mean age of 57.5 years)16. Santoro et al. divided 603 gastric cancer patients into two groups: one with ages of <45 years, and the other with ages of 46-75 years. In the younger group, 53% were females, 73% had Lauren's diffuse pattern, 59% were classified as N2-3, and 49% of the patients were in clinical stage IV. Survival rate was similar in both groups (32% between 5-10 years)19. Bando et al suggest that the age is a better prognostic marker than nodal status in patients with early gastric cancer. Of the 4321 individuals analyzed, overall survival rate was 90.2%; however, for both sexes, those who were older than 80 years showed a survival of <30%2. Kim et al. reported that age over 60 years was the only significant prognostic factor in patients with early gastric cancer, whereas the prognosis of those with advanced gastric cancer was associated with lymphovascular neoplastic invasion and degree of invasion10.

Gastric adenocarcinoma most often affects the antrum (50-60% of cases), and patients with early gastric cancer have an average five-year survival estimated at 90-95%; in advanced lesions, this rate is approximately 151,4,8,9,14,17,18. Shiraishi et al. evaluated a group of 95 patients with gastric adenocarcinoma with a diameter of >10 cm, and they found a median survival rate of 15 months. In this group of patients, the presence of regional lymph node metastasis, liver metastasis, and serosa invasion were significantly associated with the prognosis of neoplasia20. In a study conducted with 591 patients with gastric cancer, Liu et al. found that prognosis was associated with the degree of invasion and the presence of metastasis in regional lymph nodes, with no association with the tumor size15. Wang et al. determined a good prognosis for tumors measuring <2.5 cm24.

The presence of regional lymph node metastasis, depth of invasion and differentiation degree are considered the most important associated prognostic factors3,8,9,10,11,17,18,21,25. The results of this study show that there was no significant statistical relationship between nodal status and histological grade (p=0.269), presence of signet-ring cells (p=0.592), and Lauren's histological pattern (p=0.793), but with depth of invasion (p=0.001). The presence of regional lymph node metastasis was found in >50% of gastrectomy specimens, probably because they were mostly asymptomatic cancers up to advanced stages of the disease. Lauren's intestinal, diffuse, and mixed subtypes seem to have different pathogenetic basis. The intestinal subtype predominates in high-risk areas and seems to develop from precursor lesions, while the incidence of the diffuse subtype is relatively constant and has no identifiable precursor lesions. The intestinal subtype has an average age of onset of 55 years and a male/female ratio of 2:1. The diffuse gastric cancer occurs in younger patients (mean age 48 years) and has a similar prevalence between males and females3,8,9,11,13,14,17,18. In a study of 289 gastrectomy specimens, Lemes et al. reported the presence of Lauren's intestinal subtype in 178 samples (62%), with prevalence of these lesions in males (n=116), and of Borrmann I or II types. In this group, 230 specimens corresponded to advanced gastric cancer13.

According to Liu et al., the presence of lymphovascular neoplastic invasion is an important prognostic factor for gastric cancers that show no lymph node metastasis. Among the 188 patients studied by this author, 158 patients were ranked stage T1N0M0 and 30 patients were ranked stage T1N1M0, with survival rate being lower in cases where lymphatic invasion was detected15. According to Chi et al., 85 patients with stage-T3 gastric cancer and tumor measuring >8 cm had a survival rate of 33.8% in five years4. An et al. found a five-year survival rate of 26.7% for cases of Borrmann's stage IV gastric adenocarcinoma, and >61.2% for the stages I, II and III 1.

CONCLUSION

The presence of metastases in perigastric lymph nodes was associated with depth of invasion and tumor size, while the pathological stage was associated with age and histological grade. Thus, early detection of gastric cancer and extensive resection of perigastric tissues are key factors in treating and improving the survival rate of patients with this malignancy.

Footnotes

Fonte de financiamento: não há

Conflito de interesses: não há

REFERENCES

  • 1.An J, Kang TH, Choi MG, et al. Borrmann Type IV: An Independent Prognostic Factor for Survival in Gastric Cancer. J Gastrointest Surg. 2008;12(8):1364–1369. doi: 10.1007/s11605-008-0516-9. [DOI] [PubMed] [Google Scholar]
  • 2.Bando E, Kojima N, Kawamura T, et al. Prognostic value of age and sex in early gastric cancer. Br J Surg. 2004;91(9):1197–1201. doi: 10.1002/bjs.4541. [DOI] [PubMed] [Google Scholar]
  • 3.Carneiro F, Sobrinho-Simões M. Metastatic pattern of gastric carcinoma. Hum Pathol. 1996;27:213–214. doi: 10.1016/s0046-8177(96)90382-2. [DOI] [PubMed] [Google Scholar]
  • 4.Chi Z, Huang CM, Zheng CH, et al. Prognostic significance of tumor size in T3 gastric cancer. Chin J Gastroint Surg. 2011;12(2):114–116. [PubMed] [Google Scholar]
  • 5.Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–362. doi: 10.3748/wjg.v12.i3.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.He MM, Zhang DS, Wang F, et al. The role of non-curative surgery in incurable, asymptomatic advanced gastric cancer. PLos One. 2013;8(12): doi: 10.1371/journal.pone.0083921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Instituto Nacional de Câncer - INCA Estimativa 2012: incidência de câncer no Brasil. 2012. [Acessado em 22 de julho de 2012]. Available from: http://www.inca.gov.br/estimativa/2012/
  • 8.Ishigami S, Natsugoe S, Miyazono F, et al. Clinical merit of subdividing gastric cancer according to invasion of the muscularis propria. Hepatogastroenterology. 2004;51:869–871. [PubMed] [Google Scholar]
  • 9.Kappas AM, Fatouros M, Roukos DH. Is it time to change surgical strategy for gastric cancer in the United States. Ann Surg Oncol. 2004;11:727–730. doi: 10.1245/ASO.2004.05.907. [DOI] [PubMed] [Google Scholar]
  • 10.Kim B, Cho SW, Min SK, et al. Differences in prognostic factors between early and advanced gastric cancer. Hepatogastroenterology. 2011;58:1032–1040. [PubMed] [Google Scholar]
  • 11.Komuro A, Yashiro M, Iwata C, et al. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling. J Natl Cancer Inst. 2009;15:592–604. doi: 10.1093/jnci/djp058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Laurén P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  • 13.Lemes LAO, Neunschwander LC, Matta LAC, et al. Carcinoma gástrico: análise sistemática de 289 gastrectomias consecutivas em Belo Horizonte (MG) JBPML. 2003;39(1):57–65. [Google Scholar]
  • 14.Liu C, Zhang R, Lu Y, et al. Prognostic role of lymphatic vessel invasion in early gastric cancer: a retrospective study of 188 cases. Surg Oncol. 2010;19(1):4–10. doi: 10.1016/j.suronc.2008.10.003. [DOI] [PubMed] [Google Scholar]
  • 15.Liu Y, Chen XH, Meng XH, et al. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator? Hepatogastroenterology. 2012;59(114):623–626. doi: 10.5754/hge11455. [DOI] [PubMed] [Google Scholar]
  • 16.Moghimi-Dehkordi B, Safaee A, Zali MR. Survival rates and prognosis of gastric cancer using an actuarial life-table method. Asian Pacific J Cancer Prev. 2008;9:317–322. [PubMed] [Google Scholar]
  • 17.Mori M, Sakaguchi H, Akazawa K, et al. Correlation between metastatic site, histological type, and serum tumor markers of gastric carcinoma. Hum Pathol. 1995;26:504–508. doi: 10.1016/0046-8177(95)90246-5. [DOI] [PubMed] [Google Scholar]
  • 18.Roder JD, Bottcher K, Busch R, et al. Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group Cancer. 1998;82:621–631. [PubMed] [Google Scholar]
  • 19.Santoro R, Carboni F, Lepiane P, et al. Clinicopathological features and prognosis of gastric cancer in young European adults. Br J Surg. 2007;94(6):737–742. doi: 10.1002/bjs.5600. [DOI] [PubMed] [Google Scholar]
  • 20.Shiraishi N, sato K, Yasuda K, et al. Multivariate prognostic study on large gastric cancer. J Surg Oncol. 2007;96(1):8–14. doi: 10.1002/jso.20631. [DOI] [PubMed] [Google Scholar]
  • 21.Talamonti MS, Kim SP, Yao KA, et al. Surgical outcomes of patients with gastric carcinoma: the importance of primary tumor location and microvessel invasion. Surgery. 2003;134(4):720–727. doi: 10.1016/s0039-6060(03)00337-4. [DOI] [PubMed] [Google Scholar]
  • 22.Takaishi S, Okumura T, Wang TC. Gastric Cancer Stem Cells. J Clin Oncol. 2010;26(17):2876–2882. doi: 10.1200/JCO.2007.15.2603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wang HM, Huang CM, Zheng CH, et al. Tumor size as a prognbostic factor in patients with advanced gastric cancer in the lower third of the stomach. World J Gastroenterol. 2012;18(38):5470–5475. doi: 10.3748/wjg.v18.i38.5470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Wang W, Li YF, Sun XW, et al. Prognosis of 980 patients with gastric cancer after resection. Chin J Cancer. 2010;29:923–930. doi: 10.5732/cjc.010.10290. [DOI] [PubMed] [Google Scholar]
  • 25.Yin D, Li D, Sun Z, et al. Clinicopathologic features and prognosis analysis of mucinous gastric carcinoma. Med Oncol. 2012;29(2):864–870. doi: 10.1007/s12032-011-9825-z. [DOI] [PubMed] [Google Scholar]

Articles from Arquivos Brasileiros de Cirurgia Digestiva : ABCD = Brazilian Archives of Digestive Surgery are provided here courtesy of Colégio Brasileiro de Cirurgia Digestiva

RESOURCES